DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
19.53
+0.09 (0.46%)
At close: Jan 24, 2025, 4:00 PM
19.56
+0.03 (0.15%)
After-hours: Jan 24, 2025, 7:17 PM EST
DENTSPLY SIRONA Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for DENTSPLY SIRONA stock have an average target of 25.27, with a low estimate of 20 and a high estimate of 32. The average target predicts an increase of 29.39% from the current stock price of 19.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for XRAY stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 5 | 5 | 5 | 3 | 3 | 2 |
Hold | 4 | 4 | 4 | 5 | 6 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 9 | 11 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy → Hold Downgrades $30 → $20 | Strong Buy → Hold | Downgrades | $30 → $20 | +2.41% | Jan 23, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $20 | Buy → Hold | Downgrades | $20 | +2.41% | Jan 7, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +17.77% | Dec 17, 2024 |
Mizuho | Mizuho | Hold Initiates $21 | Hold | Initiates | $21 | +7.53% | Dec 4, 2024 |
UBS | UBS | Strong Buy Maintains $35 → $27 | Strong Buy | Maintains | $35 → $27 | +38.25% | Dec 3, 2024 |
Financial Forecast
Revenue This Year
3.89B
from 3.97B
Decreased by -2.02%
Revenue Next Year
3.81B
from 3.89B
Decreased by -1.88%
EPS This Year
1.87
from -0.62
EPS Next Year
1.97
from 1.87
Increased by 4.99%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.0B | 4.0B | 4.2B | ||
Avg | 3.9B | 3.8B | 3.9B | ||
Low | 3.7B | 3.6B | 3.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.2% | 3.2% | 9.0% | ||
Avg | -2.0% | -1.9% | 3.0% | ||
Low | -6.2% | -7.6% | -3.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.95 | 2.25 | 2.64 | ||
Avg | 1.87 | 1.97 | 2.26 | ||
Low | 1.78 | 1.64 | 1.87 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 19.9% | 34.0% | ||
Avg | - | 5.0% | 14.7% | ||
Low | - | -12.6% | -4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.